Search for: "ELI LILLY & CO." Results 81 - 100 of 1,006
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2006, 8:22 am
Crystal Garcia of the Terre Haute Tribune-Star, reports:TERRE HAUTE — About 175 people have come forward to share their stories to fuel the race discrimination lawsuit against Eli Lilly and Co., said one of the plaintiffs in the case, Cassandra Welch, at a public information session Wednesday night. * * * The federal lawsuit, filed April 21, alleges that black employees of Lilly have been victims of unlawful discrimination and that the company… [read post]
26 Aug 2015, 8:49 am by Gene Quinn
The United States District Court for the Southern District of Indiana ruled in favor of Eli Lilly (NASDAQ: LLY), issuing a final judgment in the Hatch-Waxman infringement litigation relating to U.S. [read post]
15 Jan 2009, 3:10 am
This just in 20 minutes ago from the AP.INDIANAPOLIS January 15, 2009, 10:56 am ET · Eli Lilly & Co. said Thursday it pleaded guilty to a charge that it illegally marketed the anti-psychotic drug Zyprexa for an unapproved use, and will pay $1.42 billion to settle civil suits and end the criminal investigation.OK folks. [read post]
27 Jan 2014, 9:47 am
DSI currently co-promotes Effient® products in the United States with Lilly. [read post]
22 Nov 2008, 12:06 pm
Lately Kolkata Patent Office issued an Indian Patent No. 225209 to Eli Lilly & Co. for crystalline non-solvated anhydrous Arzoxifene. [read post]
5 Jul 2018, 7:20 am by Overhauser Law Offices, LLC
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
5 Jul 2018, 7:20 am by Overhauser Law Offices, LLC
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
24 Aug 2012, 2:57 pm
Eli Lilly responded with an infringement suit against the generics makers. [read post]
24 Feb 2009, 9:43 pm
Seeking approval to manufacture and market a generic version of Plaintiff-Appellee Eli Lilly and Company's raloxifene hydrochloride formulation, which Lilly markets as Evista ® for the treatment and prevention of postmenopausal osteoporosis, Teva filed an ANDA with the FDA in 2006. [read post]
12 Jul 2017, 2:30 am by Matrix Legal Support Service
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd & others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
27 Dec 2006, 4:14 pm
On April 15, 2005, the Indianapolis Star reported, in a story headlined "Lilly wins Round 1 of Zyprexa battle: Appeal is certain and likely will take a year or longer", that:A federal judge Friday upheld Eli Lilly and Co.'s Zyprexa patent, giving the drugmaker a critical and clear-cut court victory over generic drug challengers trying to cash in on Lilly's top-selling drug. [read post]